Published in Cancer Genet Cytogenet on July 01, 1991
Concerted evolution of the tandem array encoding primate U2 snRNA occurs in situ, without changing the cytological context of the RNU2 locus. EMBO J (1995) 1.45
Adenovirus type 12-induced fragility of the human RNU2 locus requires U2 small nuclear RNA transcriptional regulatory elements. Mol Cell Biol (1995) 0.88
Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome. Mol Cell Biol (1993) 0.85
The transcriptionally competent U2 gene is necessary and sufficient for adenovirus type 12 induction of the fragile site at 17q21-22. Mol Cell Biol (1995) 0.81
Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action. J Clin Invest (1993) 0.77
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Production of Altered Y Chromosomes Bearing Specific Sections of the X Chromosome in Drosophila. Genetics (1961) 7.02
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc Natl Acad Sci U S A (1977) 4.35
Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A (1994) 3.86
A rapid and efficient procedure for the purification of DNA from agarose gels. Anal Biochem (1980) 3.77
Mutants affecting meiosis in natural populations of Drosophila melanogaster. Genetics (1968) 3.71
Mechanisms of meiotic drive. Annu Rev Genet (1970) 3.11
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02
Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol (1994) 2.76
Telomerase activity in normal leukocytes and in hematologic malignancies. Blood (1995) 2.71
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol (1994) 2.57
The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet (1999) 2.52
Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans. J Virol (1985) 2.40
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24
Selective assay for herpes simplex viruses expressing thymidine kinase. J Virol (1979) 2.03
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet (1997) 1.97
Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol (1981) 1.94
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res (1996) 1.87
Herpes simplex virus thymidine kinase transcripts are absent from both nucleus and cytoplasm during infection in the presence of cycloheximide. J Virol (1980) 1.86
Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69
Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology (1991) 1.66
Mapping of a 14,000-dalton antigen to early region 4 of the human adenovirus 5 genome. J Virol (1983) 1.64
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol (2000) 1.60
Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst (1996) 1.57
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. J Virol (1981) 1.55
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem (2000) 1.49
Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet (2001) 1.48
Tn5 mutagenesis of the transforming genes of human adenovirus type 5. Gene (1983) 1.41
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol (1997) 1.38
Telomerase activity in normal and malignant murine tissues. Oncogene (1995) 1.34
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer (1998) 1.34
Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene (2001) 1.31
Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme. J Gen Virol (1983) 1.29
A UV-specific endonucleolytic activity present in human cell extracts. Biochem Biophys Res Commun (1972) 1.29
Is ribonucleotide reductase the transforming function of herpes simplex virus 2? Nature (1983) 1.26
Immunological characterization of herpes simplex virus type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductase activity. J Virol (1984) 1.24
Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology (1989) 1.23
Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2. J Virol Methods (1981) 1.22
Integration and expression of viral DNA in cells transformed by host range mutants of adenovirus type 5. J Virol (1982) 1.20
Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. J Virol (1986) 1.18
Covalently closed circles of adenovirus 5 DNA. Nature (1983) 1.17
Genetic interactions between error-prone and error-free postreplication repair pathways in Saccharomyces cerevisiae. Mutat Res (1999) 1.16
Actinomycin D: effects on mouse L-cells. Biophys J (1969) 1.13
Purification and characterization of an endonuclease from calf thymus acting on irradiated DNA. Biochim Biophys Acta (1975) 1.13
The relation of protein synthesis to radiation-induced division delay in Chinese hamster cells. Radiat Res (1970) 1.09
Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg (2001) 1.09
Recovery of SD chromosomes from Drosophila melanogaster males when heterozygous with structurally different second chromosomes. Can J Genet Cytol (1974) 1.07
Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells. J Gen Virol (1990) 1.03
Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5. J Virol (1984) 0.98
Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum Mol Genet (1998) 0.97
High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somat Cell Mol Genet (1995) 0.97
Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology (1988) 0.96
Relation of Herpes simplex viruses to human malignancies. Curr Top Microbiol Immunol (1977) 0.96
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis (2002) 0.95
Telomeres and telomerase in human cancer (review). Int J Oncol (1995) 0.95
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther (2003) 0.94
Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres. Nucleic Acids Res (1999) 0.92
Histological and histochemical investigations of achondroplastic mice: a possible model of human achondroplasia. Growth (1976) 0.92
Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma. Int J Cancer (1985) 0.92
Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins. Biochem Cell Biol (1993) 0.91
Differences between horse and human haemoglobins in effects of organic and inorganic anions on oxygen binding. Biochem J (1990) 0.91
Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein. J Virol (1990) 0.91
Fragile sites and chromosome instability: the distribution of breaks induced by cis-diamine-dichloro-platinum (II) in Fanconi anemia lymphocyte cultures. Hum Genet (1991) 0.90
Differences in the levels of UV repair and in clinical symptoms in two sibs affected by xeroderma pigmentosum. Hum Genet (1980) 0.89
Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene (1998) 0.87
Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene (1994) 0.87
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Transformation by human adenoviruses. J Cell Physiol Suppl (1984) 0.86
Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome. Mol Cell Biol (1993) 0.85
Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer (1994) 0.84
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex. Mol Endocrinol (2011) 0.83
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res (1998) 0.82
Characterization of human TK- cell lines transformed to a TK+ phenotype by herpes simplex virus type 2 DNA. J Gen Virol (1979) 0.82
The transcriptionally competent U2 gene is necessary and sufficient for adenovirus type 12 induction of the fragile site at 17q21-22. Mol Cell Biol (1995) 0.81
Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells. Exp Cell Res (2001) 0.81
Cytogenetic study in lymphocytes from children exposed to ionizing radiation after the Chernobyl accident. Mutat Res (1993) 0.81
Mouse chondrocytes in monolayer culture. In Vitro Cell Dev Biol Anim (1993) 0.80
Protein kinase and ATP-binding activity associated with the 72-kdalton single-stranded DNA-binding protein from early region 2A of human adenovirus type 5. Can J Biochem Cell Biol (1985) 0.80
Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno)benzoic acid potassium salt. Mutat Res (1988) 0.80
Cytogenetic effects of 1-p-(3-methyltriazeno)benzoic acid potassium salt on human lymphocytes in vitro. Mutat Res (1987) 0.80
The responsiveness of human papillomavirus upstream regulatory regions to herpes simplex virus immediate early proteins. Virus Res (1988) 0.78
Investigations on the PGM (phosphoglucomutase) polymorphism by isoelectric focusing in Drosophila melanogaster. Biochem Genet (1990) 0.78
Specific sites for EBV association in the Namalwa Burkitt lymphoma cell line and in a lymphoblastoid line transformed in vitro with EBV. Cytogenet Cell Genet (1988) 0.78
In cell lines constitutively synthesizing a temperature-sensitive ICP4 protein of herpes simplex virus type 1, amount and function of ICP4 are both regulated by temperature. Virology (1987) 0.78
Population cytogenetics of aphidicolin-induced fragile sites. Hum Genet (1992) 0.78
Fragile site 1p13.1 in neuroblastoma patients. Cancer Genet Cytogenet (1989) 0.78
The distribution of MspI-induced breaks in human lymphocyte chromosomes and its relationship to common fragile sites. Mutat Res (1989) 0.78
Telomeres in the haemopoietic system. Ciba Found Symp (1997) 0.78
Characteristic chromosomal fragility of human embryonic cells exposed in vitro to aphidicolin. Hum Genet (1995) 0.78
Automated continuous culture of mammalian cells in suspension. Science (1970) 0.77
Hypersensitivity of lymphoblastoid lines derived from ataxia telangiectasia patients to the induction of chromosomal aberrations by etoposide (VP-16). Mutat Res (1993) 0.77
Telomeres and telomerase in normal and malignant haematologic cells. Leuk Lymphoma (1996) 0.77
Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability. Am J Med Genet (1987) 0.77